Aberrant Alternative Splicing Is Another Hallmark of Cancer

Article, Review English OPEN
Ladomery, Michael;
  • Publisher: Hindawi Publishing Corporation
  • Journal: International Journal of Cell Biology,volume 2,013 (issn: 1687-8876, eissn: 1687-8884)
  • Related identifiers: doi: 10.1155/2013/463786, pmc: PMC3786539
  • Subject: Cytology | Review Article | QH573-671 | Article Subject

The vast majority of human genes are alternatively spliced. Not surprisingly, aberrant alternative splicing is increasingly linked to cancer. Splice isoforms often encode proteins that have distinct and even antagonistic properties. The abnormal expression of splice fac... View more
  • References (37)
    37 references, page 1 of 4

    Hanahan, D., Weinberg, R. A.. The hallmarks of cancer. Cell. 2000; 100 (1): 57-70

    Hanahan, D., Weinberg, R. A.. Hallmarks of cancer: the next generation. Cell. 2011; 144 (5): 646-674

    Warburg, O.. On the origin of cancer cells. Science. 1956; 123 (3191): 309-314

    Vaupel, P., Mayer, A.. Hypoxia in cancer: significance and impact on clinical outcome. Cancer and Metastasis Reviews. 2007; 26 (2): 225-239

    Johnson, R. F., Perkins, N. D.. Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect. Trends in Biochemical Sciences. 2012; 37 (8): 317-324

    Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., Mamer, O. A., Avizonis, D., de Berardinis, R. J., Siegel, P. M., Jones, R. G.. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metabolism. 2013; 17 (1): 113-124

    Huff, V.. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nature Reviews Cancer. 2011; 11 (2): 111-121

    Pan, Q., Shai, O., Lee, L. J., Frey, B. J., Blencowe, B. J.. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature Genetics. 2008; 40 (12): 1413-1415

    Venables, J. P.. Unbalanced alternative splicing and its significance in cancer. BioEssays. 2006; 28 (4): 378-386

    Harper, S. J., Bates, D. O.. VEGF-A splicing: the key to anti-angiogenic therapeutics?. Nature Reviews Cancer. 2008; 8 (11): 880-887

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark